Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, January 2004, p. 319-322, Vol. 48, No. 1
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.1.319-322.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
FKS1 Mutations Responsible for Selective Resistance of Saccharomyces cerevisiae to the Novel 1,3-ß-Glucan Synthase Inhibitor Arborcandin C
Takao Ohyama,* Shunichi Miyakoshi, and Fujio Isono
Lead Discovery Research Laboratories, Sankyo Co., Ltd., Shinagawa-ku, Tokyo 140-8710, Japan
Received 7 August 2003/
Returned for modification 11 September 2003/
Accepted 26 September 2003

ABSTRACT
Arborcandin C is a novel antibiotic with potent antifungal activity
that inhibits 1,3-ß-glucan synthase in fungi. We examined
spontaneous
Saccharomyces cerevisiae mutants which are selectively
resistant to arborcandin C and revealed that a single amino
acid replacement in Fks1p of Asn
470 with Lys or of Leu
642 with
Ser confers selective resistance on Fks1p mutants.

INTRODUCTION
The 1,3-ß-glucan polymer is a major component of the
cell wall in yeast and filamentous fungi (
11) and is synthesized
by 1,3-ß-glucan synthase (GS). In
Saccharomyces cerevisiae,
GS consists of at least two subunits: a putative catalytic subunit
encoded by related genes
FKS1 and
FKS2 (
7,
10) and a regulatory
subunit, a GTP-bound protein encoded by
RHO1 (
16). Several types
of GS inhibitors, such as echinocandins (
5,
13), papulacandins
(
20), and FR901469 (
8), have been identified. GS inhibitors
are a new class of antifungal antibiotics with clinical significance
because of their strong fungicidal activity and low toxicity
(
1,
3).
Arborcandins are recently isolated cyclic lipopeptides which inhibit GS from Candida albicans and Aspergillus fumigatus (14) and which also have growth-inhibitory activity (14). Although we reported that arborcandin C noncompetitively inhibited GS (14), the molecular target of the inhibition still remains to be elucidated. In this study, we isolated selective arborcandin C-resistant S. cerevisiae mutants with antibiotic-resistant-GS activity and revealed that two single-amino-acid mutations in Fks1p conferred selective resistance to arborcandin C.
Standard procedures were used for DNA manipulations (17). Genetic manipulations for yeast were carried out as described previously (9). Yeast strains and plasmids used in this study are listed in Table 1. All yeast strains were derivatives of S. cerevisiae YPH250 (18). Yeast cells were grown either in YPDAU medium (2% peptone, 1% yeast extract, 20 µg of adenine sulfate/ml, 20 µg of uracil/ml, 2% glucose) or SD medium (9) supplemented appropriately. FKS1 was cloned by screening the genomic DNA library of the wild-type strain (YPH250) for complementing fks1
::LEU2 on SD medium containing 1 µg of FK506/ml. An arborcandin C resistance gene was cloned by screening the genomic DNA libraries of the arborcandin C-resistant mutants ACR79-5 and ACR1A3 for genes that conferred growth in SD medium containing 5 µg of arborcandin C/ml on YPH250. The DNA sequence was determined by automated DNA sequencer model ABI3700 with a dye terminator cycle sequencing kit (Applied Biosystems).
Growth inhibition was determined by the broth microdilution
method in a 96-well microplate using YPDAU medium. Briefly,
10
4 yeast cells were inoculated into 150 µl of medium
in each well and incubated at 30°C for 16 to 24 h in the
presence or absence of GS inhibitors. The optical density at
595 nm of the exponentially growing culture was measured by
microplate reader (ARVOsx; Perkin-Elmer).
Preparation and measurement of activity of GS from wild-type and mutant S. cerevisiae strains were performed according to the procedure described by Inoue et al. (10) and Cabib and Kang (4), respectively. The solubilized membrane fraction (10) was used as GS.

Isolation of selective arborcandin C-resistant mutants.
Arborcandin C is structurally different from echinocandins and
papulacandins (
14). To examine whether arborcandin C has a molecular
target different from those of known GS inhibitors, we took
a genetic approach. Spontaneously resistant
S. cerevisiae mutants
were isolated at a concentration of 1 µg of arborcandin
C/ml on a YPDAU medium plate. We selected two mutants, ACR79-5
and ACR1A3, which are resistant only to arborcandin C, not to
any other type of GS inhibitors, for further study. As the echinocandin-type
and papulacandin-type inhibitors, we used pneumocandin A
0 (
2)
and F-10748 C
1 (
15), respectively. As shown in Table
2, both
mutants were 100-fold more resistant to arborcandin C than the
parental wild-type strain and there was a modest change in the
susceptibility to pneumocandin A
0 and F-10748 C
1. We did not
observe significant differences between the wild-type strain
and the mutants in their phenotypes, such as their cell morphology
and calcofluor white sensitivity phenotypes, which reflect structural
changes in the cell wall (data not shown).
To determine whether the selective resistance of the mutants
to arborcandin C was due to a change of sensitivity of GS, the
sensitivity of GS from the mutants was tested. As shown in Table
3, GS from either of the resistant mutants was highly resistant
to arborcandin C. The 50% inhibitory concentration of arborcandin
C against the mutant's GS was more than 100-fold higher than
that of arborcandin C against the wild-type enzyme. On the other
hand, the sensitivity of both mutant enzymes to the other types
of GS inhibitors tested was not significantly changed. These
results suggested that the selective resistance of the mutants
was due to the selective resistance of GS.

Cloning of mutated genes responsible for selective arborcandin C resistance.
To identify the mutated genes in ACR79-5 and ACR1A3, we screened
the genomic DNA library of each mutant using the centromere-type
vector (pCE112) for plasmids conferring arborcandin C resistance
on the wild-type strain. Four and three arborcandin C-resistant
colonies were isolated by the transformation with the libraries
of ACR79-5 and ACR1A3, respectively. All plasmid DNAs recovered
from the resistant transformants conferred arborcandin C resistance
(data not shown). Partial sequence analysis of the plasmids
revealed that the minimum region conferring arborcandin C resistance
from both the mutants contained an
FKS1 locus as a complete
open reading frame (data not shown). Therefore, it was strongly
suggested that the gene mutated in both the resistant mutants
was
FKS1.

Mutation of Asn470 to Lys or Leu642 to Ser in Fks1p confers selective resistance to arborcandin C.
By DNA sequence analysis of the
FKS1 open reading frame, the
mutations in ACR79-5 and ACR1A3 were determined to be the replacement
of Asn
470 with Lys and of Leu
642 with Ser in Fks1p, respectively
(Fig.
1). We subcloned each of the mutated regions to wild-type
FKS1 and examined the effect of each mutation in the
fks1
PGAL10-FKS2 cells. In the
fks1
PGAL10-FKS2 strain,
FKS2 gene expression
was controlled by the
GAL10 promoter and suppressed in the presence
of glucose. Therefore, the effect of the substitution in Fks1p
can be analyzed under the depletion of endogenous Fks1p and
Fks2p in the
fks1
PGAL10-FKS2 cells in glucose medium. The introduction
of mutated
FKS1 (
FKS1N470K or
FKS1L642S) to the
fks1
PGAL10-FKS2 strain conferred selective resistance to arborcandin C, as shown
by arborcandin C-resistant mutants ACR79-5 and ACR1A3 (Table
2). Moreover, the GSs from cells with
FKS1N470K or
FKS1L642S conferred selective resistance to arborcandin C (Table
3). These
results show that Asn
470 and Leu
642 of Fks1p are critical amino
acids in the GS-inhibitory activity of arborcandin C and strongly
suggest that the target molecule of arborcandin C is Fks1p,
the putative catalytic subunit of GS.
The results we obtained also suggested that Asn
470 and Leu
642 in Fks1p are topologically proximate. The model of membrane
topology of Fks1p was predicted by hydropathy plot analysis
(
6). In the model, Asn
470 and Leu
642 exist in the transmembrane
domain and cytoplasmic loop domain, respectively, and Asn
470 is topologically distant from Leu
642 (Fig.
2A). On the other
hand, in the model predicted by the PHDhtm server (
http://cubic.bioc.columbia.edu/predictprotein),
Asn
470 and Leu
642 exist at the first and third extracellular
regions, respectively, and it is possible that these amino acid
residues are close to each other (Fig.
2B). Our results support
the model of Fks1p by the PHDhtm server and contribute to the
understanding of the exact structure of Fks1p.
Amino acid residues corresponding to Asn
470 and Leu
642 and the
primary structure of the regions around those amino acid residues
are well conserved among arborcandin-sensitive fungi (Fig.
3).
However, these amino acid residues are also conserved in
Cryptococcus neoformans, which is resistant to arborcandins (
14). Although
C. neoformans has GS and although the unique
FKS1 gene of this
organism is essential for its growth (
19),
C. neoformans is
resistant to all the known GS inhibitors (
8,
12,
20). A common
mechanism of resistance to these GS inhibitors, including arborcandins,
may exist in
C. neoformans.
Isolation of the selective arborcandin C-resistant mutants and
the identification of amino acids responsible for the resistance
provide new insights into the interaction between Fks1p and
GS inhibitors. Based on the results of this study, future studies
will monitor the direct interaction between arborcandin C and
the N-terminal putative extracellular region. Structural analysis
of the N-terminal region of Fks1p would also help to improve
the antifungal activity of arborcandins.

Nucleotide sequence accession numbers.
Whole nucleotide sequences of
FKS1 open reading frames of the
wild type, ACR79-5, and ACR1A3 are available in the GenBank
database under the accession numbers
AY395693,
AY395694, and
AY395695, respectively.

FOOTNOTES
* Corresponding author. Mailing address: Lead Discovery Research Laboratories, Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan. Phone: 81-3-3492-3131. Fax: 81-3-5436-8578. E-mail:
takaoo{at}shina.sankyo.co.jp.


REFERENCES
1 - Abruzzo, G. K., A. M. Flattery, C. J. Gill, L. Kong, J. G. Smith, V. B. Pikounis, J. M. Balkovec, A. F. Bouffard, J. F. Dropinski, H. Rosen, H. Kropp, and K. Bartizal. 1997. Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob. Agents Chemother. 41:2333-2338.[Abstract]
2 - Adefarati, A. A., O. D. Hensens, E. T. Jones, and J. S. Tkacz. 1992. Pneumocandins from Zalerion arboricola. V. Glutamic acid- and leucine-derived amino acids in pneumocandin A0 (L-671,329) and distinct origins of the substituted proline residues in pneumocandins A0 and B0. J. Antibiot. 45:1953-1957.[Medline]
3 - Bartizal, K., C. J. Gill, G. K. Abruzzo, A. M. Flattery, L. Kong, P. M. Scott, J. G. Smith, C. E. Leighton, A. Bouffard, J. F. Dropinski, and J. Balkovec. 1997. In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872). Antimicrob. Agents Chemother. 41:2326-2332.[Abstract]
4 - Cabib, E., and M. S. Kang. 1987. Fungal 1,3-ß-glucan synthase. Methods Enzymol. 138:637-642.[Medline]
5 - Debono, M., and R. S. Gordee. 1994. Antibiotics that inhibit fungal cell wall development. Annu. Rev. Microbiol. 48:471-497.[CrossRef][Medline]
6 - Douglas, C. M., F. Foor, J. A. Marrinan, N. Morin, J. B. Nielsen, A. M. Dahl, P. Mazur, W. Baginsky, W. Li, M. el-Sherbeini, J. A. Clemas, S. M. Mandala, B. R. Frommer, and M. B. Kurtz. 1994. The Saccharomyces cerevisiae FKS1 (ETG1) gene encodes an integral membrane protein which is a subunit of 1,3-ß-D-glucan synthase. Proc. Natl. Acad. Sci. USA 91:12907-12911.[Abstract/Free Full Text]
7 - Eng, W. K., L. Faucette, M. M. McLaughlin, R. Cafferkey, Y. Koltin, R. A. Morris, P. R. Young, R. K. Johnson, and G. P. Livi. 1994. The yeast FKS1 gene encodes a novel membrane protein, mutations in which confer FK506 and cyclosporin A hypersensitivity and calcineurin-dependent growth. Gene. 151:61-71.[CrossRef][Medline]
8 - Fujie, A., T. Iwamoto, H. Muramatsu, T. Okudaira, I. Sato, T. Furuta, Y. Tsurumi, Y. Hori, M. Hino, S. Hashimoto, and M. Okuhara. 2000. FR901469, a novel antifungal antibiotic from an unidentified fungus no. 11243. II. In vitro and in vivo activities. J. Antibiot. 53:920-927.[Medline]
9 - Guthrie, C., and G. R. Fink (ed.). 1991. Methods in enzymology, vol. 194. Guide to yeast genetics and molecular biology. Academic Press, Inc., San Diego, Calif.
10 - Inoue, S. B., N. Takewaki, T. Takasuka, T. Mio, M. Adachi, Y. Fujii, C. Miyamoto, M. Arisawa, Y. Furuichi, and T. Watanabe. 1995. Characterization and gene cloning of 1,3-ß-glucan synthase from Saccharomyces cerevisiae. Eur. J. Biochem. 231:845-854.[Medline]
11 - Klis, F. M. 1994. Review: cell wall assembly in yeast. Yeast 10:851-869.[CrossRef][Medline]
12 - Krishnarao, T. V., and J. N. Galgiani. 1997. Comparison of the in vitro activities of the echinocandin LY303366, the pneumocandin MK-0991, and fluconazole against Candida species and Cryptococcus neoformans. Antimicrob. Agents Chemother. 41:1957-1960.[Abstract]
13 - Kurtz, M. B., and C. M. Douglas. 1997. Lipopeptide inhibitors of fungal glucan synthase. J. Med. Vet. Mycol. 35:79-86.[Medline]
14 - Ohyama, T., Y. Kurihara, Y. Ono, T. Ishikawa, S. Miyakoshi, K. Hamano, M. Arai, T. Suzuki, H. Igari, Y. Suzuki, and M. Inukai. 2000. Arborcandins A, B, C, D, E and F, novel 1,3-ß-glucan synthase inhibitors: production and biological activity. J. Antibiot. 53:1108-1116.[Medline]
15 - Ohyama, T., Y. Iwadate-Kurihara, T. Hosoya, T. Ishikawa, S. Miyakoshi, K. Hamano, and M. Inukai. 2002. F-10748 A1, A2, B1, B2, C1, C2, D1 and D2, novel papulacandins. J. Antibiot. 55:758-763.[Medline]
16 - Qadota, H., C. P. Python, S. B. Inoue, M. Arisawa, Y. Anraku, Y. Zheng, T. Watanabe, D. E. Levin, and Y. Ohya. 1996. Identification of yeast Rho1p GTPase as a regulatory subunit of 1,3-ß-glucan synthase. Science 272:279-281.[Abstract]
17 - Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
18 - Sikorski, R. S., and P. Hieter. 1989. A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics 122:19-27.[Abstract/Free Full Text]
19 - Thompson, J. R., C. M. Douglas, W. Li, C. K. Jue, B. Pramanik, X. Yuan, T. H. Rude, D. L. Toffaletti, J. R. Perfect, and M. Kurtz. 1999. A glucan synthase FKS1 homologue in Cryptococcus neoformans is single copy and encodes an essential function. J. Bacteriol. 181:444-453.[Abstract/Free Full Text]
20 - VanMiddlesworth, F., M. N. Omstead, D. Schmatz, K. Bartizal, R. Fromtling, G. Bills, K. Nollstadt, S. Honeycutt, M. Zweerink, G. Garrity, and K. Wilson. 1991. L-687-781, a new member of the papulacandin family of ß-1,3-D-glucan synthesis inhibitors. I. Fermentation, isolation and biological activity. J. Antibiot. 44:45-51.[Medline]
Antimicrobial Agents and Chemotherapy, January 2004, p. 319-322, Vol. 48, No. 1
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.1.319-322.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Katiyar, S. K., Edlind, T. D.
(2009). Role for Fks1 in the Intrinsic Echinocandin Resistance of Fusarium solani as Evidenced by Hybrid Expression in Saccharomyces cerevisiae. Antimicrob. Agents Chemother.
53: 1772-1778
[Abstract]
[Full Text]
-
Katiyar, S., Pfaller, M., Edlind, T.
(2006). Candida albicans and Candida glabrata Clinical Isolates Exhibiting Reduced Echinocandin Susceptibility.. Antimicrob. Agents Chemother.
50: 2892-2894
[Abstract]
[Full Text]
-
Park, S., Kelly, R., Kahn, J. N., Robles, J., Hsu, M.-J., Register, E., Li, W., Vyas, V., Fan, H., Abruzzo, G., Flattery, A., Gill, C., Chrebet, G., Parent, S. A., Kurtz, M., Teppler, H., Douglas, C. M., Perlin, D. S.
(2005). Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical Candida sp. Isolates. Antimicrob. Agents Chemother.
49: 3264-3273
[Abstract]
[Full Text]